ROS1-GOPC/FIG: A Novel Gene Fusion in Hepatic Angiosarcoma

Oncotarget - United States
doi 10.18632/oncotarget.26521
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

ROS1-ADGRG6: A Case Report of a Novel ROS1 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Crizotinib

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

The British Hepatic Angiosarcoma Register

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
1981English

A Case of Hepatic Angiosarcoma Treated With Paclitaxel

Acta Hepatologica Japonica
Hepatology
2015English

Hepatic Angiosarcoma Masquerading as Hemangioma: A Challenging Differential Diagnosis

Acta Medica Portuguesa
Medicine
2017English

Identification of a Novel Fusion Gene HMGA2-EGFR in Glioblastoma

International Journal of Cancer
Cancer ResearchOncology
2017English

Hepatic Angiosarcoma Arising in an Adult Mesenchymal Hamartoma

International Seminars in Surgical Oncology
2007English

OA02.02 Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Clinical Activity of Crizotinib in Lung Adenocarcinoma Harboring a Rare ZCCHC8-ROS1 Fusion

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.09-09 Evaluation of a Novel ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in NSCLC Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy